Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
David Thomas, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01423643
First received: August 23, 2011
Last updated: February 22, 2016
Last verified: February 2016